SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Marijuana Stocks
CGC 1.130-6.2%2:06 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: roto6/1/2020 2:18:40 PM
1 Recommendation

Recommended By
alwaysbmiki

  Read Replies (1) of 3484
 
Isracann Biosciences, Inc. ISCNF
finance.yahoo.com

Israel Gives Final Go-Ahead for Cannabis Exports: Here's Who Could Profit -- CFN Media
Isracann Biosciences Inc. (CSE: IPOT) (OTC Pink: ISCNF) is Israel's first pure-play cannabis firm wholly focused on becoming the nation's premier, low-cost cannabis producer. The company has a joint venture agreement in place with a built 55,000 sq. ft. farm that's expandable to 110,000 sq. ft. in the near-term and has access to over two million sq. ft. of private land.

"Our Hefer Valley farm is making great strides," said Isracann's VP of Operations, Matt Chatterton in a recent press release. "We engaged a specialist Israeli consultant to advance the certification of farm to EU-GMP standards thereby paving the way for our export distribution. In addition, the related post-harvest export facility is nearing readiness."

In addition to its production, Isracann entered into a MOU earlier this year to distribute cannabis throughout European end markets. The distributor will import products through the Republic of Malta, subject to compliance and regulations, and is currently preparing a regional processing facility designed to meet EU-GMP standards.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext